Low-Dose naltrexone tested for long COVID fatigue relief
NCT ID NCT05430152
First seen Apr 04, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This study tested whether a low dose of the drug naltrexone can reduce fatigue and other symptoms in people with Post-COVID fatigue syndrome. 160 adults aged 19-69 who had confirmed COVID-19 and ongoing fatigue took part. The goal was to see if this safe, well-tolerated drug could improve energy, pain, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-VIRAL FATIGUE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Women's Health Research Institute
Vancouver, British Columbia, V6H 3N1, Canada
Conditions
Explore the condition pages connected to this study.